Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001225208-14-007555)

Filing Details

Accession Number:: 0001225208-14-007555
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-03-05 17:36:57
Reporting Period:: 2014-03-04

Filing Date:: 2014-03-05
Accepted Time:: 2014-03-05 17:36:57
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
78003	Pfizer Inc	PFE	Pharmaceutical Preparations (2834)	135315170

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1263544	Sally Susman	Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017	Executive Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-03-04	500	$32.67	240,722	No	4	S	Direct
Common Stock	Disposition	2014-03-04	1,600	$32.65	239,122	No	4	S	Direct
Common Stock	Disposition	2014-03-04	1,700	$32.66	237,422	No	4	S	Direct
Common Stock	Disposition	2014-03-04	1,700	$32.62	235,722	No	4	S	Direct
Common Stock	Disposition	2014-03-04	2,500	$32.64	233,222	No	4	S	Direct
Common Stock	Disposition	2014-03-04	4,200	$32.63	229,022	No	4	S	Direct
Common Stock	Disposition	2014-03-04	5,200	$32.56	223,822	No	4	S	Direct
Common Stock	Disposition	2014-03-04	5,649	$32.60	218,173	No	4	S	Direct
Common Stock	Disposition	2014-03-04	6,200	$32.61	211,973	No	4	S	Direct
Common Stock	Disposition	2014-03-04	9,600	$32.57	202,373	No	4	S	Direct
Common Stock	Disposition	2014-03-04	13,251	$32.59	189,122	No	4	S	Direct
Common Stock	Disposition	2014-03-04	15,485	$32.58	173,637	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	395	Indirect	By Rule 16b-3 Plan